Zobrazeno 1 - 10
of 166
pro vyhledávání: '"William G. Goodman"'
Autor:
John Mark Stephens, Kathleen M. Fox, Pooja Desai, Sunfa Cheng, William G. Goodman, Jessica B. Kendrick
Publikováno v:
Hemodialysis International. 26:243-254
This study described control of parathyroid hormone (PTH), phosphorus, and corrected calcium in adults initiating calcimimetics in small dialysis organizations after the introduction of etelcalcetide.This retrospective study using Visonex Clarity ele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e325cbfc671c31de71612f9fd891658
https://doi.org/10.1111/hdi.12996
https://doi.org/10.1111/hdi.12996
Autor:
James Lai, Edward F. Nemeth, Kevin J. Martin, Jiahong Xu, Debra Drayer, Donald T. Ward, Carol Moore, William G. Goodman, Yun Chon
Publikováno v:
J Am Soc Nephrol
Goodman, W G, Ward, D T, Martin, K J, Drayer, D, Moore, C, Xu, J, Lai, J, Chon, Y & Nemeth, E F 2022, ' Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia ', Journal of the American Society of Nephrology : JASN, vol. 33, no. 1, pp. 201-212 . https://doi.org/10.1681/ASN.2021060825
Goodman, W G, Ward, D T, Martin, K J, Drayer, D, Moore, C, Xu, J, Lai, J, Chon, Y & Nemeth, E F 2022, ' Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia ', Journal of the American Society of Nephrology : JASN, vol. 33, no. 1, pp. 201-212 . https://doi.org/10.1681/ASN.2021060825
BACKGROUND: Phosphorus levels in the range seen clinically among patients undergoing dialysis have been reported to attenuate calcium receptor activation and modify parathyroid hormone (PTH) release from isolated parathyroid glands in vitro. Some cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4159c89124255059d327b10b8253af7
https://europepmc.org/articles/PMC8763177/
https://europepmc.org/articles/PMC8763177/
Autor:
Sunfa Cheng, Daniel Muenz, Angelo Karaboyas, Pooja Desai, Kathleen M. Fox, Ronald L. Pisoni, William G. Goodman, Yunji Hwang, Bruce G. Robinson
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Calcimimetic therapy, including oral cinacalcet and intravenous (IV) etelcalcetide, is often used to control parathyroid hormone (PTH) levels in hemodialysis (HD) patients. In a head-to-head clinical trial, etelcalcetide was super
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a73d618ab99df9f109a02eecf572dc74
https://doi.org/10.1093/ndt/gfab123.003
https://doi.org/10.1093/ndt/gfab123.003
Autor:
Anjay Rastogi, Beatrice Drambarean, Thomas L. Nickolas, Anis A Rauf, Sunfa Cheng, David Henner, William G. Goodman, Brenda Dyson, Kathleen M. Fox, William T Kendrick, Michael C. Singer, Lisa Koester Wiedemann, Teresa M Gerbeling, Pooja Desai, Jessica Kendrick
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims The 2017 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) guidelines inform clinical practice for the management of secondary hyperparathyroidism (SHPT) internationally; howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba4b0738cde5506d018d7086aec7ac4
https://doi.org/10.1093/ndt/gfab086.009
https://doi.org/10.1093/ndt/gfab086.009
Autor:
Gary L. Skiles, Abhinaya Iyer, Katheryne Z. Edson, Benjamin M. Wu, William G. Goodman, Raju Subramanian
Publikováno v:
Kidney International Reports, Vol 1, Iss 1, Pp 24-33 (2016)
Kidney International Reports
Kidney International Reports
Introduction Etelcalcetide, a novel calcimimetic agonist of the calcium-sensing receptor for treatment of secondary hyperparathyroidism in chronic kidney disease patients on hemodialysis, is a d -amino acid linear heptapeptide with a d -cysteine that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06eccb0620f063fe3d02fe8de7463f67
http://www.sciencedirect.com/science/article/pii/S2468024916300031
http://www.sciencedirect.com/science/article/pii/S2468024916300031
Autor:
David C. Wheeler, Jürgen Floege, Charles A. Herzog, Tilman B. Drüeke, Bastian Dehmel, Kenneth W. Mahaffey, Safa Abdalla, Gérard M. London, William G. Goodman, Sharon M. Moe, Geoffrey A. Block, Patrick S. Parfrey, John P. Middleton, Ricardo Correa-Rotter, Patrick H. Pun, Glenn M. Chertow
Publikováno v:
Hemodialysis International. 20:421-431
Among patients receiving hemodialysis, abnormalities in calcium regulation have been linked to an increased risk of cardiovascular events. Cinacalcet lowers serum calcium concentrations through its effect on parathyroid hormone secretion and has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8a51a01017ebfe0850c77ca7a4998cf
https://doi.org/10.1111/hdi.12382
https://doi.org/10.1111/hdi.12382
Autor:
David C. Wheeler, Ricardo Correa-Rotter, Tilman B. Drüeke, Kenneth W. Mahaffey, Jürgen Floege, Safa Abdalla, Geoffrey A. Block, Gérard M. London, William G. Goodman, Charles A. Herzog, Bastian Dehmel, Sharon M. Moe, Glenn M. Chertow, Patrick S. Parfrey
Publikováno v:
Journal of the American Society of Nephrology. 26:1466-1475
Fractures are frequent in patients receiving hemodialysis. We tested the hypothesis that cinacalcet would reduce the rate of clinical fractures in patients receiving hemodialysis using data from the Evaluation of Cinacalcet HCl Therapy to Lower Cardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a115424408f254d4372a738cc960ea
https://doi.org/10.1681/asn.2014040414
https://doi.org/10.1681/asn.2014040414
Autor:
Piergiorgio Messa, William G. Goodman, Andrzej Wiecek, John Cunningham, Vassilios Liakopoulos, Mariano Rodriguez
Publikováno v:
Seminars in Dialysis. 28:497-507
Until the discovery of calcimimetics, the management of secondary hyperparathyroidism (SHPT) relied exclusively on treatment with phosphate binders, vitamin D derivatives or surgical parathyroidectomy with limited success. The therapeutic use of calc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c41383c529cdfcef25db7c443896a4
https://doi.org/10.1111/sdi.12357
https://doi.org/10.1111/sdi.12357
Autor:
Chun-Ya Han, Xiaodong Li, William G. Richards, Shawn T. Alexander, James E. Tomlinson, Longchuan Yu, Charles W. Dean, Denise Dwyer, William G. Goodman, Marina Stolina, Kelly Hensley
Publikováno v:
Calcified Tissue International
Etelcalcetide, a novel peptide agonist of the calcium-sensing receptor, prevents vascular calcification in a rat model of renal insufficiency with secondary hyperparathyroidism. Vascular calcification occurs frequently in patients with chronic kidney
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbe8a90cef2131d730b9f3a56d53b290
https://pubmed.ncbi.nlm.nih.gov/29038882
https://pubmed.ncbi.nlm.nih.gov/29038882
Autor:
Frank Pétavy, Maureen Reiner, Paolo Raggi, Pablo Ureña-Torres, Eugenie Pedagogos, Carmel M. Hawley, Juergen Floege, William G. Goodman
Publikováno v:
Nephrology Dialysis Transplantation. 28:146-152
BackgroundThe ADVANCE study assessed the progression of vascular and cardiac valve calcification in 360 hemodialysis patients with secondary hyperparathyroidism (sHPT) assigned randomly to treatment either with cinacalcet plus low-dose vitamin D (≤
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b191bbd69f3adf2d924d66a0d17495b2
https://doi.org/10.1093/ndt/gfs356
https://doi.org/10.1093/ndt/gfs356